Elaina Mann
Impact in
- Oncology top 2%
- PARP inhibition in cancer therapy
- Pancreatic and Hepatic Oncology Research
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 2
- PARP inhibition in cancer therapy 2
-
- Ovarian cancer diagnosis and treatment 1
- Co-authors
- S.J. Enna (1 shared paper)Anne P. Teitelbaum (2 shared papers)Robert A. Nissenson (2 shared papers)Jane Winer (2 shared papers)Claude D. Arnaud (2 shared papers)Stefan Hubert Boeck (1 shared paper)Jeff Isaacson (1 shared paper)Michael Haas (1 shared paper)
- Journals
- Cancer Discovery (1 paper)Journal of Clinical Oncology (1 paper)Advances in experimental medicine and biology (1 paper)Clinical Cancer Research (1 paper)Life Sciences (1 paper)
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
Elaina Mann
9 papers receiving 1.9k citations
Elaina Mann's Hit Papers
Peers
Comparison fields: 5 of 77
- Oncology 1.3k
- Reproductive Medicine 414
- Cancer Research 518
- Pulmonary and Respiratory Medicine 415
- Molecular Biology 719
Countries citing papers authored by Elaina Mann
This map shows the geographic impact of Elaina Mann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elaina Mann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elaina Mann more than expected).
Fields of papers citing papers by Elaina Mann
This network shows the impact of papers produced by Elaina Mann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elaina Mann. The network helps show where Elaina Mann may publish in the future.
Co-authors
The 15 scholars most cited alongside Elaina Mann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial Hit paper breakdown → | 2016 | 985 |
| 2 | BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma Hit paper breakdown → | 2018 | 348 |
| 3 | 2016 | 256 | |
| 4 | 2016 | 165 | |
| 5 | 2013 | 137 | |
| 6 | 2014 | 33 | |
| 7 | 1986 | 31 | |
| 8 | 1982 | 20 | |
| 9 | 1986 | 1 |
About Elaina Mann
Elaina Mann is a scholar working on Oncology, Reproductive Medicine, Genetics, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 9 papers that have together received 2.0k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (2 papers), Receptor Mechanisms and Signaling (2 papers), Lung Cancer Treatments and Mutations (2 papers), BRCA gene mutations in cancer (1 paper), Ion channel regulation and function (1 paper), Ovarian cancer diagnosis and treatment (1 paper), Metabolism, Diabetes, and Cancer (1 paper) and Neurotransmitter Receptor Influence on Behavior (1 paper). The work is most often cited by research in Oncology (1.3k citations), Reproductive Medicine (414 citations), Cancer Research (518 citations), Pulmonary and Respiratory Medicine (415 citations) and Molecular Biology (719 citations). Elaina Mann has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include S.J. Enna, Anne P. Teitelbaum, Robert A. Nissenson, Jane Winer, Claude D. Arnaud, Stefan Hubert Boeck, Jeff Isaacson, Michael Haas, Volker Heinemann and Stephan Krüger. Their work appears in journals such as Cancer Discovery, Journal of Clinical Oncology, Advances in experimental medicine and biology, Clinical Cancer Research and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.